Stryker Corporation et al v. Ridgeway et al
Filing
427
OPINION ; signed by Judge Robert Holmes Bell ; this document appears in the following associated cases: 1:13-cv-01066-RHB, 1:14-cv-00889-RHB (Judge Robert Holmes Bell, kcb)
UNITED STATES DISTRICT COURT
FOR THE WESTERN DISTRICT OF MICHIGAN
SOUTHERN DIVISION
STRYKER CORPORATION, et al.,
Plaintiffs,
Case No. 1:13-CV-1066
v.
HON. ROBERT HOLMES BELL
CHRISTOPHER RIDGEWAY, et al.,
Defendants.
and
STONE SURGICAL, LLC,
Plaintiff,
v.
Case No. 1:14-CV-889
STRYKER CORPORATION, et al.,
Defendants.
/
OPINION
This matter is before the Court on Defendant Christopher Ridgeway’s motion for
partial summary judgment against Plaintiffs Howmedica Osteonics Corp. and Stryker
Corporation as to their claims for breach of contract (Count I) and breach of fiduciary duty
(Count III). (ECF No. 326.)1 For the reasons that follow, the motion will be denied.
1
This motion is also found at ECF No. 282 in consolidated Case No. 1:14-CV-889.
I.
Under Rule 56(a) of the Federal Rules of Civil Procedure, summary judgment is
proper if there is no genuine issue as to any material fact and the moving party is entitled to
judgment as a matter of law. In evaluating a motion for summary judgment the Court must
look beyond the pleadings and assess the proof to determine whether there is a genuine need
for trial. Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 587 (1986). If
the moving party carries its burden of showing there is an absence of evidence to support a
claim, then the nonmoving party must demonstrate by affidavits, depositions, answers to
interrogatories, and admissions on file that there is a genuine issue of material fact for trial.
Celotex Corp. v. Catrett, 477 U.S. 317, 324-25 (1986). The mere existence of a scintilla of
evidence in support of the nonmoving party’s position is not sufficient to create a genuine
issue of material fact. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 252 (1986). The
proper inquiry is “whether the evidence presents a sufficient disagreement to require
submission to a jury or whether it is so one-sided that one party must prevail as a matter of
law.” Id. at 251-52.
II.
A. BREACH OF CONTRACT CLAIM
Ridgeway contends that even if Plaintiffs succeed on their claim that Ridgeway signed
the non-compete agreement that is attached as Exhibits A & B to Plaintiffs’ amended
complaint (ECF Nos. 23-1, 23-2), they still cannot prevail on their breach of contract claim
2
because the alleged agreement was made with Howmedica Leibinger, Inc. The agreement
provides in the first paragraph that it is between “Howmedica Leibinger, Inc., d/b/a Stryker
Leibinger, a subsidiary of Stryker Corporation (“Company”) and
(“Employee”).”
Ridgeway has presented evidence that he was employed by Howmedica Osteonics, not by
Howmedica Leibinger. (Ridgeway Decl. ¶ 2; ECF No. 37-2; 2008-2013 W-2s, ECF No.
329). He also points out that there is no evidence that he ever signed a non-compete
agreement with Howmedica Osteonics. Ridgeway contends that under Michigan law,2 only
an employer may obtain a non-compete agreement, and there is no evidence that Ridgeway
was an employee of Howmedica Leibinger.
Section 4a of the Michigan Antitrust Reform Act (“MARA”), Mich. Comp. Laws
§ 445.771 et seq., specifically permits non-compete agreements between an employer and an
employee:
An employer may obtain from an employee an agreement or covenant which
protects an employer’s reasonable competitive business interests and expressly
prohibits an employee from engaging in employment or a line of business after
termination of employment if the agreement or covenant is reasonable as to its
duration, geographical area, and the type of employment or line of business.
To the extent any such agreement or covenant is found to be unreasonable in
any respect, a court may limit the agreement to render it reasonable in light of
the circumstances in which it was made and specifically enforce the agreement
as limited.
Mich. Comp. Laws § 445.774a(1) (emphasis added).
2
Ridgeway brings this motion pursuant to Michigan law, but reserves his claim that
Louisiana law applies.
3
Contrary to Ridgeway’s assertions, Michigan does not prohibit non-compete
agreements outside of the employer-employee context. Michigan has a common-law rule
of reason that contemplates the enforceability of non-competition agreements that qualify as
reasonable. This common law rule of reason, which is embodied within § 2 of the MARA,
was not abolished by the enactment of section 4a of the MARA. Bristol Window & Door,
Inc. v. Hoogenstyn, 650 N.W.2d 670, 678-80 (Mich. Ct. App. 2002) (holding that MARA
§ 4a does not prohibit noncompetition agreements between employers and independent
contractors).
Alternatively, Ridgeway contends that even if Michigan law does not prohibit noncompete agreements outside of the employer/employee context, Plaintiffs, who were not
parties to the contract, should not be able to enforce it. In support of this argument,
Ridgeway notes that the restrictions of the non-compete agreement are expressly limited to
“sales territories in which Employee worked for Company, Stryker Leibinger during the
twelve (12) months prior to his/her termination.” (Non-Compete Agreement 3, ECF No. 232.) He also notes that restrictive covenants are narrowly construed. In contrast to other
contracts whose legality, validity, and enforceability is generally presumed, “noncompetition
agreements are disfavored as restraints on commerce and are only enforceable to the extent
they are reasonable.” Coates v. Bastian Bros., Inc., 741 N.W.2d 539, 545 (Mich. Ct. App.
2007); see also Whirlpool Corp. v. Burns, 457 F. Supp. 2d 806, 811 (W.D. Mich. 2006)
(Bell, C.J.) (noting that restrictive covenants must be narrowly construed). In assessing the
4
reasonableness of a noncompetition agreement, courts consider not only the the clause’s
duration, geographic scope, and the type of employment prohibited, but also the
reasonableness of the competitive business interests justifying the clause. St Clair Med., PC
v. Borgiel, 715 N.W.2d 914, 919 (Mich. Ct. App. 2006); Teachout Sec. Servs., Inc. v.
Thomas, No. 293009, 2010 WL 4104685, at *2 (Mich. Ct. App. Oct. 19, 2010). “A covenant
not to compete may not be read to extend beyond an employer’s ‘reasonable competitive
business interests.’” Whirlpool, 457 F. Supp. 2d at 812 (quoting Kelsey–Hayes Co. v.
Maleki, 765 F. Supp. 402, 406 (E.D. Mich.), vacated pursuant to settlement, 889 F. Supp.
1583 (E.D. Mich. 1991)). The party seeking enforcement bears the burden of demonstrating
the validity of the agreement. Coates, 741 N.W.2d at 545.
Ridgeway also contends that Plaintiffs cannot enforce the non-compete agreement
because he was not terminated by Stryker Leibinger. The form non-compete agreement
prohibits competitive activity for one year “following the termination of Employee’s
employment with Company.” (Non-Compete Agreement 3.)
“Company” is defined as
Stryker Leibinger. Ridgeway contends that because he was not terminated by Stryker
Leibinger, he could not have breached the non-compete agreement following his termination.
In response to Ridgeway’s motion, Plaintiffs have presented documentation from the
time Ridgeway was hired which supports a finding that he was originally hired by
Howmedica Leibinger d/b/a Stryker Leibinger. His employment offer comes from Stryker
Leibinger and welcomes him to Stryker Leibinger. Ridgeway faxed his signed employment
5
forms back to Stryker Leibinger and he identified Stryker Leibinger as his division. (Hiring
Package, ECF No. 373-5.) The evidence is sufficient to create an issue of fact as to whether
Ridgeway was ever employed by Stryker Leibinger.
Plaintiffs contend that Ridgeway was an employee of Stryker CMF, the corporate
history of which Plaintiffs have outlined through the declaration of Dean Bergy, the Vice
President and Corporate Secretary for Stryker Corporation, as follows: Stryker acquired
Howmedica Leibinger in December 1998; from December 1998 until December 2006,
Howmedica Leibinger, a/k/a Stryker Leibinger, was a direct subsidiary of Stryker; Stryker
Leibinger developed medical devices used in craniomaxillofacial (“CMF”) surgery and
neurosurgery; on December 1, 2006, Howmedica Leibinger merged into Stryker; at some
undisclosed time, following a series of internal corporate transactions, Howmedica
Leibinger, a/k/a Stryker Leibinger, was transferred into and became a division of Howmedica
Osteonics known as Stryker CMF. (Bergy Decl. ¶¶ 7-8, 10-11.) Although Plaintiffs have
presented evidence that Howmedica Osteonics is a wholly-owned subsidiary of Stryker,
Plaintiffs have not identified when or how Howmedica Osteonics came into being.
Plaintiffs have also presented evidence that the form non-compete agreement with
Stryker Leibinger expressly provides that the protection provided to the “Company” under
the agreement “extends to Company’s related or associated entities, as well as to their
successors and/or assigns.” (Non-Compete Agreement ¶ 9.) Plaintiffs contend that as a
result of this language, both Stryker and Howmedica Osteonics have standing to enforce the
6
contract. Plaintiffs also assert that the non-compete agreement was properly assigned to
Howmedica Osteonics under the express terms of the agreement.
In his reply, Ridgeway contends that there is no reliable evidence that Howmedica
Leibinger, Inc. became Howmedica Osteonics Corp. He notes that Plaintiffs have offered
no documentary evidence in support of their contention that Stryker Leibinger was
transferred into Howmedica Osteonics. All they have presented is the vague assertion by
Bergy that at some undisclosed time, through a series of undisclosed internal corporate
transactions, Stryker Leibinger was transferred into and became a division of Howmedica
Osteonics.
Ridgeway contends that Bergy’s declaration is inadmissible under Rule
801because it is hearsay, and is inadmissible under Rule 1002 because Plaintiffs have not
supplied the original writing to prove its content. Ridgeway also contends that Bergy’s
claims about the transfer of Howmedica Leibinger into Howmedica Osteonics are refuted by
the fact that as recently as 2012, Stryker has represented Howmedica Leibinger, Inc. as a
separate corporation entitled to enforce the form non-compete agreement. (Krupinski Letter
to Cruikshank, ECF No. 378-3; 03/29/2010 Green Non-Compete Agreement, ECF No. 3785.)
For purposes of this motion for summary judgment the Court is satisfied that Bergy’s
declaration regarding the corporate structure and history of Stryker and its affiliates is
sufficient to create an issue of fact for trial. Based on the evidence provided, the Court
concludes that Ridgeway is not entitled to summary judgment on Plaintiffs’ breach of
7
contract claim. Whether Ridgeway was ever employed by Stryker Leibinger, whether Stryker
Leibinger had a reasonable competitive business interest justifying a non-compete agreement,
whether the non-compete agreement was assigned to Howmedica Osteonics, and whether
Stryker and Howmedica Osteonics were related or associated entities who could reasonably
enforce the non-compete agreement all present questions of fact for trial.
Plaintiffs have also pointed out that their breach of contract claim is based not only
on breaches of the non-compete agreement, but also on breaches of the Employee
Confidentiality and Intellectual Property Agreement that Ridgeway entered into with Stryker
Corporation, “including its subsidiaries, operating divisions, and affiliates” on May 28, 2002.
In his reply brief, Ridgeway contends that Stryker’s claim under the confidentiality
agreement fails because Plaintiffs have not identified which of them owned the confidential
information that was allegedly misappropriated. Ridgeway contends that each Plaintiff has
failed to satisfy its individual burden of proof.
Ridgeway’s motion for summary judgment did not address the confidentiality
agreement. Accordingly, Plaintiffs were not put to their proofs on this issue. This issue is
not properly before the Court.
Ridgeway contends, in the alternative, that he is entitled to summary judgment against
Stryker on the breach of contract claim because he never competed with Stryker. In support
of his motion, Ridgeway relies on Stryker’s admission that it did not have sales
representatives selling the products that Ridgeway planned to sell for Biomet. (Shinevare
8
Decl. ¶ 9, ECF No. 327-4.) In addition, Ridgeway contends that the non-compete agreement
only restricted activities directed at the “Company’s Customers.” Ridgeway contends that
his customers were Howmedica Osteonics’ customers, not Stryker’s customers, and that
Stryker accordingly has no claim under the non-compete agreement. Finally, Ridgeway
contends that he never actually sold any products for Biomet.
The Court is not unsympathetic to Ridgeway’s attempt to separate the various Stryker
corporate entities. In their complaint, Plaintiffs refer to Stryker and Howmedica Osteonics
collectively as Stryker. (Am. Compl. 1, ECF No. 23.) At other times, Plaintiffs maintain that
Stryker and Howmedica Osteonics are separate corporations each of which maintains a
separate legal status. (Shinevare Decl. ¶¶ 6, 7, ECF No. 327-4; Shinevare Dep. 19, 21, ECF
No. 327-5.) In response to this motion, Plaintiffs have introduced a new entity they refer to
as Stryker CMF. The confusion may work against Plaintiffs at trial. Nevertheless, it appears
that Ridgeway is demanding a more distinct separation between the corporate entities than
is legally required. Plaintiffs have presented evidence that Ridgeway not only competed
against Stryker CMF but that he also competed against Stryker by soliciting Stryker’s
customer to go to Biomet. The Court is satisfied that there is at least a question of fact as to
whether the several Stryker affiliates had overlapping interests, and whether Ridgeway’s
actions could be viewed as competition with Stryker, as distinct from Stryker CMF.
Accordingly, Ridgeway’s motion for summary judgment on Plaintiffs’ breach of contract
claim will be denied.
9
B. BREACH OF FIDUCIARY DUTY CLAIM
Ridgeway contends that Plaintiffs’ breach of fiduciary duty claim fails because he was
not an employee of Stryker, and, with respect to Howmedica Osteonics, he was not a high
level officer or director, nor was he an employee who made strategic business decisions. He
asserts that he was a salesman who, effective January 1, 2012, became a manager of three
other salesmen. (Rideway Decl. ¶ 2, ECF No. 327-2.) He further states that he “did not
direct strategic planning and did not direct any production, manufacturing, or development
of products.” (Id.)
Under Michigan law, fiduciary duties arise “‘out of the relation subsisting between
two persons of such a character that each must repose trust and confidence in the other and
must exercise a corresponding degree of fairness and good faith.’” Wysong Corp. v. M.I.
Indus., 412 F. Supp. 2d 612, 632 (E.D. Mich. 2005) (quoting Portage Aluminum Co. v.
Kentwood Nat’l Bank, 307 N.W.2d 761, 763 (Mich. Ct. App. 1981)). To prevail on a breach
of a fiduciary duty claim, a plaintiff must show that the “‘position of influence has been
acquired and abused,” or the “confidence has been reposed and betrayed.” Vicencio v.
Ramirez, 536 N.W.2d 280, 284 (Mich. Ct. App. 1995)). Id. The general rule is that the
employer-employee relationship does not give rise to a fiduciary relationship unless the
employee is a high-level employee, or if there is a specific agency relationship. Dana Ltd.
v. Am. Axle & Mfg. Holdings, Inc., No. 1:10-CV-450, 2012 WL 2524008, at *12 (W.D.
Mich. June 29, 2012) (Bell, J.)
10
Plaintiffs do not assert that Ridgeway was a high-level employee. Instead, they base
their fiduciary duty claim on their assertion that Ridgeway acted as an agent for both Stryker
and Howmedica Osteonics. “‘The law will not permit an agent to act in a dual capacity in
which his interest conflicts with his duty, without a full disclosure of the facts to his
principal.’” Nedschroef Detroit Corp. v. Bemas Enters. LLC, No. CIV. 14-10095, 2015 WL
2453511, at *6 (E.D. Mich. May 22, 2015) (quoting Sweeney & Moore v. Chapman, 294
N.W. 711, 712-713 (Mich. 1940)).
Plaintiffs have presented evidence that Ridgeway was responsible for Stryker’s Neuro
Spine ENT (“NSE”) business, which is a division of Stryker Corporation. (Mercado Decl.
¶ 17, ECF No. 8-1.) Stryker has also presented evidence that, in that capacity, Ridgeway was
responsible for marketing and selling Stryker’s NSE products, cultivating and growing
relationships with surgeons and hospitals, negotiating with customers on Stryker NSE’s
behalf, and recruiting and training new Stryker NSE sales representatives. (Mercado Decl.
¶ 17; Ridgeway Dep. 93, 270-75; Ridgeway 10/16/2012 email, ECF No. 376-6.)
Plaintiffs have presented evidence that as a sales representative for Stryker CMF, a
division of Howmedica Osteonics, Ridgeway was responsible for cultivating relationships
with surgeons, providing technical product information, coordinating training on Stryker
CMF products, providing technical assistance, and generally acting as the face of Stryker to
its clients. (Mercado Decl. ¶ 9, ECF No. 8-1.) When Ridgeway became a district sales
manager, he assumed greater responsibilities, including recruiting and training new sales
11
representatives, developing and implementing strategies to maximize sales in his territory,
and helping to negotiate sales, pricing, and contracts with customers. (Krupinski Dep. ¶ 11,
ECF No. 8-1; Ridgeway Dep. 277-79; Ridgeway 10/16/2012 email, ECF No. 376-6.)
Plaintiffs have alleged that Ridgeway breached his fiduciary duties to them by, among
other things, failing to protect their interests, misusing their confidential and proprietary
information, operating a separate but related medical business, inflating sales for his personal
benefit and to Plaintiffs’ detriment, and interfering with and usurping Plaintiffs’ business
opportunities. (Am. Compl. ¶ 164.)
Plaintiffs have presented sufficient evidence to create issues of fact as to whether
Ridgeway had an agency relationship with Stryker and/or Howmedica Osteonics that would
give rise to a fiduciary duty. Accordingly, Ridgeway’s motion for summary judgment on
Plaintiffs’ breach of fiduciary duty claim will be denied.
III.
For the reasons stated herein, Ridgeway’s motion for summary judgment on Plaintiffs’
breach of contract and fiduciary duty claims (ECF No. 326) will be denied.
Dated: November 19, 2015
/s/ Robert Holmes Bell
ROBERT HOLMES BELL
UNITED STATES DISTRICT JUDGE
12
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?